Authors: Xie K et al.
Anesthesiology, February 13, 2026, 10.1097/ALN.0000000000005918
This review examines the expanding role of private equity investment in anesthesiology and places it within the broader context of healthcare consolidation, financial pressures, and workforce challenges in the United States. The authors describe how the rapid growth of private equity in healthcare—now representing hundreds of billions of dollars in investment—has increasingly reached anesthesiology, a specialty estimated to represent a $26 billion industry.
The article begins by outlining two key structural forces shaping modern healthcare organizations: horizontal and vertical integration. Horizontal integration involves consolidation among similar healthcare entities, such as physician groups merging into larger practices to achieve economies of scale. Vertical integration occurs when organizations at different levels of healthcare delivery combine—for example, physicians becoming employees of hospital systems or insurers acquiring physician practices. Both forms of integration have contributed to increasing consolidation across healthcare, influencing how anesthesia services are organized and delivered.
Private equity investment represents a distinct model within this consolidation trend. Private equity firms typically acquire physician practices using leveraged buyouts, often financing acquisitions with substantial debt. These investments are usually structured with a defined exit timeline of approximately three to seven years, during which firms attempt to increase the value of the acquired entity before selling it to another investor. One commonly used strategy is the “roll-up” model, in which private equity firms purchase multiple smaller practices and merge them into a large regional or national organization.
The authors note that anesthesiology has become an attractive specialty for private equity due to several factors. Procedural medicine continues to expand with an aging population, increasing demand for anesthesia services. At the same time, reimbursement pressures—especially declining Medicare payment rates for anesthesia services—have placed financial strain on smaller practices. Between 2000 and 2020, inflation-adjusted Medicare payments per anesthesia service declined by approximately 20.8%, while demand for procedures increased. As a result, many hospitals now provide financial stipends to anesthesia groups to maintain staffing. These financial pressures have made smaller practices more vulnerable to consolidation and outside investment.
Private equity investment in anesthesia grew rapidly during the 2010s. Between 2013 and 2016, anesthesiologists represented approximately one-third of physicians working in practices acquired by private equity firms. By 2019, private equity controlled roughly 18.8% of the anesthesia market, representing a sixfold increase in market concentration over the previous decade. Large acquisitions—such as the $9.9 billion purchase of Envision Healthcare by Kohlberg Kravis Roberts—illustrate the scale of investment entering the specialty.
The review highlights several potential benefits of private equity partnerships for anesthesia groups. The most obvious advantage is access to capital. Private equity funding can allow practices to expand geographically, invest in information technology infrastructure, improve revenue cycle management, and standardize quality monitoring systems. Larger organizations may also achieve economies of scale and gain greater negotiating power with hospitals and insurers. In some cases, integration into larger networks has been associated with improved operational efficiency and improved patient satisfaction metrics.
Another potential benefit is administrative relief for clinicians. As healthcare systems grow increasingly complex—with regulatory compliance, billing challenges, electronic records, and quality reporting requirements—many physicians prefer to focus on clinical practice rather than business management. Private equity–backed organizations often centralize these administrative functions.
However, the article also outlines several significant concerns. A key issue is the shift in governance when physician owners become employees of a private equity–controlled organization. This transition may reduce physician autonomy in clinical operations, staffing decisions, and long-term strategy. Private equity investors typically focus on maximizing financial return during their investment window, which may conflict with clinicians’ longer-term goals related to patient care, workforce stability, and institutional relationships.
Another concern involves workforce dynamics. Healthcare labor accounts for roughly half of operating costs in many organizations, making staffing a major target for efficiency improvements. Some studies in other medical specialties suggest that private equity–backed practices may operate with lower staffing levels or higher turnover rates. These changes could increase clinician workload and potentially contribute to burnout or reduced continuity of care.
Evidence regarding quality of care in private equity–owned healthcare organizations remains mixed. Some studies have reported increases in hospital-acquired complications or declines in patient experience metrics, while others have demonstrated improvements in quality indicators and operational performance. The authors emphasize that the current research base remains limited and inconsistent, particularly within anesthesiology.
The review also discusses the broader workforce challenges facing anesthesiology. The specialty continues to face staffing shortages driven by rising demand for procedures, an aging physician workforce, and limited expansion of residency training positions. Surveys suggest that a significant portion of anesthesiologists are considering reducing hours or leaving practice within the next few years. Although the number of certified registered nurse anesthetists and anesthesiologist assistants is increasing, workforce dynamics and supervision requirements create ongoing logistical challenges.
Private equity investment may partially address these workforce pressures by providing capital for recruitment and competitive compensation. However, concerns remain about whether productivity-driven models could exacerbate workload pressures or alter the culture of anesthesia groups.
Regulatory scrutiny of private equity investment in healthcare is also increasing. The Federal Trade Commission has begun investigating consolidation within certain anesthesia markets, including legal actions involving U.S. Anesthesia Partners. Although recent court decisions have not determined that existing private equity structures violate antitrust law, regulators are likely to continue monitoring consolidation within the specialty.
The authors conclude that private equity will likely remain an influential force in anesthesiology as healthcare consolidation continues. The long-term impact on costs, workforce stability, training, and quality of care remains uncertain. Continued research, increased transparency, and thoughtful regulatory oversight will be important to ensure that financial investment aligns with the goals of high-quality patient care.
What You Should Know
Private equity investment in anesthesia has expanded rapidly over the past decade and now represents a significant portion of the specialty’s organizational structure.
Financial pressures—including declining Medicare anesthesia payments and rising operational costs—have contributed to consolidation and outside investment in anesthesia practices.
Private equity partnerships may provide capital, operational resources, and negotiating leverage with hospitals and insurers.
However, concerns remain regarding physician autonomy, workforce stability, potential productivity pressures, and the long-term impact on quality of care.
Because research in anesthesiology remains limited, evidence from other specialties such as dermatology, ophthalmology, and urology is often used to anticipate potential outcomes.
Key Points
Private equity firms typically invest in healthcare organizations for three to seven years before selling the investment.
Consolidation strategies such as roll-ups allow private equity firms to combine multiple small anesthesia practices into large regional organizations.
Approximately one-third of physicians working in practices acquired by private equity firms between 2013 and 2016 were anesthesiologists.
Private equity investment can provide capital for technology, expansion, recruitment, and administrative infrastructure.
Potential concerns include loss of physician ownership, productivity-driven practice models, workforce turnover, and uncertain long-term effects on patient care.
Regulatory scrutiny of private equity consolidation in healthcare is increasing, particularly in the anesthesiology market.
Thank you to Anesthesiology for allowing us to summarize this article.